Sertraline, escitalopram and tianeptine related abnormal movements but not with bupropion: A case report

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 7, 2006, Pages 1337-1339

  Ozalp, Elvan ^a   Soygur, Haldun ^a   Cankurtaran, Eylem S ^a   Turhan, Levent ^a   Cekic, Tuǧba ^a   Akarsu, Eyüp S ^b   Palaoglu, Ozden ^b   Ayhan, Ismail H ^b  

^a ANKARA ONCOLOGY EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Bupropion; Escitalopram; Extrapyramidal symptoms; Tianeptine

Indexed keywords

AMFEBUTAMONE; BIPERIDEN; ESCITALOPRAM; LORAZEPAM; SERTRALINE; TIANEPTINE;

ADULT; AKATHISIA; ARTICLE; CASE REPORT; DEPRESSION; EXTRAPYRAMIDAL SYNDROME; HUMAN; MALE; MOTOR DYSFUNCTION; PARKINSONISM;

ADULT; BUPROPION; CITALOPRAM; DOPAMINE UPTAKE INHIBITORS; DYSKINESIAS; HUMANS; MALE; MENTAL DISORDERS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 33747067091     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.03.002     Document Type: Article

References (17)

1. Ascher J.A., Cole J.O., Colin J.N., and Feighner J.P. Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 56 9 (1995) 395-401
2. Damsa C., Bumb A., Bianchi-Demicheli F., Vidailhet P., Sterck R., Andreoli A., et al. "Dopamine dependent" side effects of selective serotonin reuptake inhibitors: a clinical review. J Clin Psychiatry 65 8 (2004) 1064-1068 [Aug]
3. Detweiler M.B., and Harpold G.J. Bupropion induced acute dystonia. Ann Pharmacother 36 2 (2002) 251-254 [Feb]
4. Gill H.S., DeVane C.L., and Risch S.C. Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypotheses. J Clin Psychopharmacol 17 (1997) 377-389
5. Gillman M.A., and Sandyk R. Parkinsonism induced by a monoamine oxidase inhibitor. Postgrad Med J Mar 62 725 (1986) 235-236
6. Gönül A.S., and Aksu M. SSRI-induced parkinsonism may be an early sign of future Parkinson's disease. J Clin Psychiatry 60 6 (1999) 410
7. Jimenez F.J., and Molina A.J. Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors. CNS Drugs 14 5 (2000) 367-379
8. Lamouchi T., Grira M., Benslamia L., Harzallah M.S., and Benammou S. Extrapyramidal syndrome worsened by tianeptine. Therapie 59 4 (2004) 481-482 [Jul-Aug]
9. Lu R., Hurley A.D., and Gourley M. Dystonia induced by mirtazapine. J Clin Psychiatry 63 5 (2002) 452-453 [May]
10. Lyons K.E., Pahwa R., Comella C.L., Eisa M.S., Elble R.J., Fahn S., et al. Benefits and risks of pharmacological treatments for some movement disorders essential tremor. Drug Safety 26 7 (2003) 461-481
11. McRea A.L. Escitalopram. Curr Opin Investig Drugs 3 (2002) 1225-1229
12. Nguyen N., Pradel V., Micallef J., Montastruc J.L., and Blin O. Drug-induced parkinsonism syndromes. Therapie 59 1 (2004) 105-112 [Jan-Feb]
13. Pact V., and Giduz T. Mirtazapine treats resting tremor, essential tremor, and levodopa-induced dyskinesias. Neurology 53 5 (1999) 1154 [Sep]
14. Pahwa R., and Lyons K.E. Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study. Mov Disord 18 5 (2003) 584-587 [May]
15. Schillevoort I., van Puijenbroek E.P., and de Boer A. Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reports. Int Clin Psychopharmacol 17 (2002) 75-79
16. Strouse T.B., Salehmoghaddam S., and Spar J.E. Delirium and parkinsonism in a bupropion-treated liver transplant recipient. J Clin Psychiatry 54 12 (1993) 489-490 [Dec]
17. Wagstaff A.J., Ormrod D., and Spencer C.M. Tianeptine: a review of its use in depressive disorders. CNS Drugs 15 3 (2001) 231-259